{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:03:16Z","timestamp":1791547396537,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY005722"],"award-info":[{"award-number":["P30EY005722"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01 EY021798"],"award-info":[{"award-number":["R01 EY021798"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jtos.2021.03.009","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:40:25Z","timestamp":1617237625000},"page":"271-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Meibomian gland dysfunction is suppressed via selective inhibition of immune responses by topical LFA-1\/ICAM antagonism with lifitegrast in the allergic eye disease (AED) model"],"prefix":"10.1016","volume":"21","author":[{"given":"Pali P.","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9651-9875","authenticated-orcid":false,"given":"Chen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2021.03.009_bib1","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/00006324-199009000-00010","article-title":"Prevalence of Meibomian gland dysfunction","volume":"67","author":"Hom","year":"1990","journal-title":"Optom Vis Sci : official publication of the American Academy of Optometry"},{"key":"10.1016\/j.jtos.2021.03.009_bib2","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for","volume":"52","author":"Schaumberg","year":"2011","journal-title":"MGD. Investigative ophthalmology & visual science"},{"key":"10.1016\/j.jtos.2021.03.009_bib3","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2021.03.009_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12886-015-0132-x","article-title":"Meibomian gland dysfunction: hyperkeratinization or atrophy?","volume":"15","author":"Jester","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jtos.2021.03.009_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.exer.2017.06.020","article-title":"Meibomian glands, meibum, and meibogenesis","volume":"163","author":"Butovich","year":"2017","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.03.009_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.03.009_bib7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.exer.2003.09.019","article-title":"Functional aspects of the tear film lipid layer","volume":"78","author":"Bron","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2021.03.009_bib8","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.03.009_bib9","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.ophtha.2012.03.004","article-title":"Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease","volume":"119","author":"Denoyer","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.03.009_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aas9164","article-title":"Neutrophils cause obstruction of eyelid sebaceous glands in inflammatory eye disease in mice","volume":"10","author":"Reyes","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtos.2021.03.009_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41385-018-0089-1","article-title":"Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model","volume":"12","author":"Saban","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064193","article-title":"Ocular mucosal CD11b+ and CD103+ mouse dendritic cells under normal conditions and in allergic immune responses","volume":"8","author":"Khandelwal","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.03.009_bib13","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.ajpath.2012.02.015","article-title":"Blocking CCR7 at the ocular surface impairs the pathogenic contribution of dendritic cells in allergic conjunctivitis","volume":"180","author":"Schlereth","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jtos.2021.03.009_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2020.12.005","article-title":"Aggregated neutrophil extracellular traps occlude Meibomian glands during ocular surface inflammation","volume":"20","author":"Mahajan","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2021.03.009_bib15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2147\/OPTH.S110557","article-title":"Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye disease","volume":"10","author":"Semba","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.03.009_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/ml2002482","article-title":"Discovery and development of potent LFA-1\/ICAM-1 antagonist SAR 1118 as an ophthalmic solution for treating dry eye","volume":"3","author":"Zhong","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jtos.2021.03.009_bib17","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.4049\/jimmunol.144.12.4579","article-title":"The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells","volume":"144","author":"Van Seventer","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3389\/fimmu.2018.00952","article-title":"LFA-1 in T Cell migration and differentiation","volume":"9","author":"Walling","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib19","first-page":"1797","article-title":"Emerging treatment options for meibomian gland dysfunction","volume":"7","author":"Qiao","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jtos.2021.03.009_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000680","article-title":"A review on evidence-based treatments for meibomian gland dysfunction","volume":"46","author":"Lam","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jtos.2021.03.009_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87001","article-title":"Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring","volume":"1","author":"Ahadome","year":"2016","journal-title":"JCI insight"},{"key":"10.1016\/j.jtos.2021.03.009_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87012","article-title":"Classical dendritic cells mediate fibrosis directly via the retinoic acid pathway in severe eye allergy","volume":"1","author":"Ahadome","year":"2016","journal-title":"JCI insight"},{"key":"10.1016\/j.jtos.2021.03.009_bib23","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1167\/iovs.14-16186","article-title":"Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease","volume":"56","author":"Lee","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2021.03.009_bib24","article-title":"Ocular allergy modulation to hi-dose antigen sensitization is a Treg-dependent process","volume":"8","author":"Lee","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jtos.2021.03.009_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1189\/jlb.3A0815-357RR","article-title":"Secondary allergic T cell responses are regulated by dendritic cell-derived thrombospondin-1 in the setting of allergic eye disease","volume":"100","author":"Smith","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jtos.2021.03.009_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-4939-7896-0_5","article-title":"Induction and characterization of the allergic eye disease mouse model","volume":"1799","author":"Reyes","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jtos.2021.03.009_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ophtha.2016.09.025","article-title":"Lifitegrast for the treatment of dry eye disease: results of a phase III, randomized, double-masked, placebo-controlled trial (OPUS-3)","volume":"124","author":"Holland","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2021.03.009_bib28","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni.2416","article-title":"Induction and molecular signature of pathogenic TH17 cells","volume":"13","author":"Lee","year":"2012","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib29","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.4049\/jimmunol.1203172","article-title":"Cutting edge: the pathogenicity of IFN-\u03b3-producing Th17 cells is independent of T-bet","volume":"190","author":"Duhen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12890-019-0899-2","article-title":"Increased IFN-\u03b3-producing Th17\/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease","volume":"19","author":"Xu","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jtos.2021.03.009_bib31","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.4049\/jimmunol.1602144","article-title":"IFN-gamma-Expressing Th17 cells are required for development of severe ocular surface autoimmunity","volume":"199","author":"Chen","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/ICO.0000000000002235","article-title":"A 6-week, prospective, randomized, single-masked study of lifitegrast ophthalmic solution 5% versus thermal pulsation procedure for treatment of inflammatory meibomian gland dysfunction","volume":"39","author":"Tauber","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2021.03.009_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4049\/jimmunol.1000366","article-title":"Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage","volume":"185","author":"Boniface","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib34","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.4049\/jimmunol.161.10.5138","article-title":"LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production","volume":"161","author":"Salomon","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib35","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1164\/ajrccm.149.5.8173758","article-title":"The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat","volume":"149","author":"Rabb","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtos.2021.03.009_bib36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/ni984","article-title":"Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1","volume":"4","author":"Perez","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jtos.2021.03.009_bib37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.celrep.2016.06.065","article-title":"Inflammatory Th17 cells express integrin \u03b1v\u03b23 for pathogenic function","volume":"16","author":"Du","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jtos.2021.03.009_bib38","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.4049\/jimmunol.1600737","article-title":"Ex-Th17 (nonclassical Th1 cells are functionally distinct from classical Th1 and Th17 cells and are not constrained by regulatory T cells","volume":"6","author":"Basdeo","year":"2017","journal-title":"Journal of Immunulogy"},{"key":"10.1016\/j.jtos.2021.03.009_bib39","doi-asserted-by":"crossref","first-page":"1254665","DOI":"10.1126\/science.1254665","article-title":"Intersection of population variation and autoimmunity genetics in human T cell activation","volume":"345","author":"Ye","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jtos.2021.03.009_bib40","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1172\/JCI114111","article-title":"Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro","volume":"83","author":"Smith","year":"1989","journal-title":"J Clin Invest"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012421000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:41:34Z","timestamp":1761540094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012421000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":40,"alternative-id":["S1542012421000203"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2021.03.009","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meibomian gland dysfunction is suppressed via selective inhibition of immune responses by topical LFA-1\/ICAM antagonism with lifitegrast in the allergic eye disease (AED) model","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2021.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}